5 Reasons Biogen’s Shares Have Dropped 36% in 2024

cafead

Administrator
Staff member
  • cafead   Nov 14, 2024 at 11:22: AM
via A slow launch for Alzheimer’s medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a few of the factors that have sent Biogen’s shares down this year.

article source